Evidence map›Paper›PMID 40579452›Full record

ArticleScientific reports2025

Evolutionary unpredictability in cancer model systems.

Subhayan Chattopadhyay, Jenny Karlsson, Michele Ferro, Adriana Mañas, Ryu Kanzaki, Elina Fredlund, Andrew J Murphy, Christopher L Morton, Natalie Andersson, Mary A Woolard and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Subhayan ChattopadhyayDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. subhayan.chattopadhyay@med.lu.se.
Jenny KarlssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Michele FerroDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Adriana MañasDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Ryu KanzakiDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Elina FredlundDivision of Pediatrics, Clinical Sciences, Translational Cancer Research, Lund University, Lund, Sweden.
Andrew J MurphyDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, USA.
Christopher L MortonDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, USA.
Natalie AnderssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Mary A WoolardDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, USA.
Karin HanssonDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Katarzyna RadkeDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Andrew M DavidhoffDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, USA.
Sofie MohlinDivision of Pediatrics, Clinical Sciences, Translational Cancer Research, Lund University, Lund, Sweden.
Kristian PietrasDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Daniel BexellDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
David GisselssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the advent of advanced molecular prognostic tools, it is still difficult to predict the course of disease for cancer patients at the individual level. This lack of predictability is also reflected in many experimental cancer model systems, begging the question of whether certain biological aspects of cancer (eg. growth, evolution etc.) can ever be anticipated or if there remains an inherent unpredictability to cancer, similar to other complex biological systems. We demonstrate by a combination of agent-based mathematical modelling, analysis of patient-derived xenograft model systems from multiple cancer types, and in-vitro culture that certain conditions increase stochasticity of the clonal landscape of cancer growth. Our findings indicate that under those conditions, the cancer genome may behave as a complex dynamic system, making its long-term evolution inherently unpredictable.

Indexed as

Models, BiologicalNeoplasmsAnimalsCell Line, TumorHumansMiceModels, TheoreticalXenograft Model Antitumor Assays

Identifiers

PMID40579452
PMCPMC12205069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.